GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » EV-to-EBITDA

Epsilon Healthcare (ASX:EPN) EV-to-EBITDA : -3.02 (As of May. 04, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Epsilon Healthcare's enterprise value is A$9.69 Mil. Epsilon Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was A$-3.21 Mil. Therefore, Epsilon Healthcare's EV-to-EBITDA for today is -3.02.

The historical rank and industry rank for Epsilon Healthcare's EV-to-EBITDA or its related term are showing as below:

ASX:EPN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.75   Med: -2.68   Max: -0.69
Current: -3.02

During the past 6 years, the highest EV-to-EBITDA of Epsilon Healthcare was -0.69. The lowest was -28.75. And the median was -2.68.

ASX:EPN's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 14.53 vs ASX:EPN: -3.02

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-04), Epsilon Healthcare's stock price is A$0.024. Epsilon Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was A$-0.011. Therefore, Epsilon Healthcare's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Epsilon Healthcare EV-to-EBITDA Historical Data

The historical data trend for Epsilon Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare EV-to-EBITDA Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial -6.41 -4.41 -4.99 -2.18 -0.91

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.18 - -0.91 -

Competitive Comparison of Epsilon Healthcare's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epsilon Healthcare's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's EV-to-EBITDA falls into.



Epsilon Healthcare EV-to-EBITDA Calculation

Epsilon Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9.688/-3.21
=-3.02

Epsilon Healthcare's current Enterprise Value is A$9.69 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epsilon Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was A$-3.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare  (ASX:EPN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Epsilon Healthcare's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.024/-0.011
=At Loss

Epsilon Healthcare's share price for today is A$0.024.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epsilon Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was A$-0.011.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Epsilon Healthcare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (ASX:EPN) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines